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The Eya1 gene encodes a transcriptional co-activator that acts with Six1 to control the development of
different organs. However, Six1-Eya1 interactions and functional roles in mesenchymal cell proliferation
and differentiation as well as alveolarization during the saccular stage of lung development are still
unknown. Herein, we provide the ﬁrst evidence that Six1 and Eya1 act together to regulate mesenchymal
development as well as alveolarization during the saccular phase of lung morphogenesis. Deletion of
either or both Six1 and Eya1 genes results in a severe saccular phenotype, including defects of
mesenchymal cell development and remodeling of the distal lung septae and arteries. Mutant lung
histology at the saccular phase shows mesenchymal and saccular wall thickening, and abnormal
proliferation of α-smooth muscle actin-positive cells, as well as increased mesenchymal/ﬁbroblast cell
differentiation, which become more sever when deleting both genes. Our study indicates that SHH but
not TGF-β signaling pathway is a central mediator for the histologic alterations described in the saccular
phenotype of Eya1/ or Six1/ lungs. Indeed, genetic reduction of SHH activity in vivo or inhibition of
its activity in vitro substantially rescues lung mesenchymal and alveolar phenotype of mutant mice at the
saccular phase. These ﬁndings uncover novel functions for Six1–Eya1–SHH pathway during the saccular
phase of lung morphogenesis, providing a conceptual framework for future mechanistic and translational
studies in this area.
& 2013 Elsevier Inc. All rights reserved.Introduction
Lung development is a conserved process and well studied in
mice, which represent an ideal model for investigating mechan-
isms controlling lung morphogenesis and congenital respiratory
diseases in humans. The development of murine lung starts at
embryonic day (E) 9.5, and is divided histologically into pseudo-
glandular stage (E9.5–E16.5), canalicular stage (E16.6–E17.4),
saccular stage (E17.5—post-natal day (P5) and alveolar stage
(P5–P30) (Warburton et al., 2010).
Mammalian lung development begins when two primary buds,
each consisting of three cell layers: the inner epithelium, the
surrounding mesenchymal stroma, and a thin outer mesothelium,
arise from the laryngotracheal groove in the ventral foregut. Thell rights reserved.
ute, Developmental Biology,
ren′s Hospital Los Angeles,
Angeles, CA 90027, USA.
l-Hashash).cellular composition of the pulmonary mesenchyme is complex
and involves the distinct patterning of different cell types. Early
distal lung mesenchyme differentiates to smooth muscle, carti-
lages, endothelial cells of blood vessels and pericytes (deMello
et al., 1997; Partanen et al., 1996). Postnatally, the distal mesoderm
gives rise to myoﬁbroblasts in the tips of the alveolar septae
(Bostrom et al., 1996; Kapanchi and Gabbiani, 1997). Other cell
types, including stromal ﬁbroblasts, interstitial lipoﬁbroblasts, and
lymphatic vessels are also found in the lung (McGowan and
Torday, 1997). Yet little is known about the functional roles of
transcription factors in mesodermal lung development.
In mammals, Eya1-4 and homeobox sine oculis (Six) transcription
factor gene families are co-expressed and regulate the development
of several organs (Xu et al., 1997a, 1997b; Ford et al., 1998; Coletta
et al., 2004). Eya1 / or Six1 / mouse embryos have defects in the
proliferation and survival of the precursor cells of multiple organs,
and die at birth (Xu et al., 1999, 2002; Li et al., 2003; Zou et al., 2004).
Haploinsufﬁciency for human EYA1 or SIX1 leads to branchio-oto-
renal syndrome (Abdelhak et al., 1997; Ruf et al., 2004). Eya1 and Six1
gene products participate in protein-protein interactions (Buller et al.,
K. Lu et al. / Developmental Biology 382 (2013) 110–123 1112001). We have recently shown that genetic deletion of either Eya1
or Six1 gene in mice results in severe lung hypoplasia, which is
characterized by a severe reduction of epithelial branching, and a
marked increase of both mesenchymal cellularity and SHH signaling
activity (El-Hashash et al., 2011a, b). Yet the synergistic regulation of
mesenchymal and epithelial cell proliferation/differentiation, as well
as SHH signaling activity by Six1 and Eya1 genes during lung
morphogenesis is unknown.
Herein, we tested the involvement of Six1 and Eya1 transcrip-
tion factors, together with SHH signaling pathway in the control of
mesenchymal cell proliferation/differentiation as well as alveolar-
ization during saccular lung development. Our results from loss-
and gain-of-function analyses indicate that Eya1 and Six1 genes act
together to regulate mesenchymal and epithelial cell proliferation/
differentiation in the developing lung. Eya1 and Six1 probably
function together to regulate saccular lung development by con-
trolling SHH signaling activity levels.Materials and methods
Animals
Eya1 / , Six1 / and Shhf/f, as well as Spc-rtTA+/-trans-
genic and tet(O)CMV-Cre-transgenic mice, and their genotyping
have been published (Xu et al., 1999, 2002; Perl et al., 2002; Laclef
et al., 2003a, b; Bassères et al., 2006). Eya1;Six1 compound
homozygous or heterozygous mice were generated by cross-
ing mice carrying mutant alleles of Eya1 and Six1. Conditional
Eya1 /; Spc-rtTA+/-tet(o) Cre+/-ShhΔ/WT (hereafter known
as Eya1/-ShhΔ/WT) mutant mice were generated as described
(El-Hashash et al., 2011a).
Six1+/;Shhf/WT female mice were generated by intercrossing
Six1+/ mice with the Shhf/f mouse line. Six1+/-Spc-rtTA+/-tet(o)
Cre+/ mice were generated by intercrossing Six1+/ mice with
the Spc-rtta+/-tet(o)Cre+/+ mouse line previously generated in
our laboratory. The resulting Six1+/-Spc-rtTA+/-tet(o)Cre+/
mouse males were intercrossed with Six1+/;Shhf/WT females to
decrease 50% of SHH activity in the distal epithelium by generating
Six1 /; Spc-rtTA+/-tet(o) Cre+/-ShhΔ/WT (hereafter known as
Six1 /-ShhΔ/WT) mutant mice for analysis. Pregnant Six1+/;
Shhf/WT females were maintained on doxycycline containing food
from E6.5 until sacriﬁced. Reduction of SHH expression in com-
pound mutant lungs was conﬁrmed by real-time PCR/Western blot
as compared to lungs of Six1 / or Eya1/ littermates. For all
experiments, wildtype littermates were used as controls. In addi-
tion, no changes in lung phenotype or protein expression were
evident in controls: DOX-fed Spc-rtTa and Spc-rtTa-tet(O) Cre mice
(data not shown).
Phenotype analyses, antibody staining, Western blot
and co-immunoprecipitation
Fluorescent staining on parafﬁn sections or ﬁxed MLE-15 cells,
immunoperoxidase staining, Western blot and co-immunopre-
cipitation were performed in triplicates using commercially available
antibodies following the manufacturer′s instructions and standard
protocols as we described (El-Hashash et al., 2011a, b, c).
Embryonic lung culture and treatment with cyclopamine
Murine lungs were dissected from E14.5 embryos and cultured
in 12-well cluster dishes on a rocker platform for 4 to 5 days as
described (Rubin et al., 2004). They were exposed to 5 μmol/l
cyclopamine, which proved to be not toxic by us (El-Hashash et al.,
2011b), for 4 days in culture.Cell culture and transfection
MLE15 cells were grown in culture as described by Tefft et al.
(2002). Transfection of cells with siRNAs was performed as we
described (El-Hashash et al., 2011c). There is no change in cells of
blank controls or Lipofectamine controls, and their data are not
presented. The knockdown/overexpression efﬁciency was ana-
lyzed by Western blotting/immunostaining of targeted protein.
Lung morphometry and proliferation index
The mean linear intercept (MLI) on E18.5 lungs was calculated
following previously published protocols (Thurlbeck, 1967; Neptune
et al., 2003; Shu et al., 2007). Brieﬂy, we captured digital images at
both 200 and 400magniﬁcation. Then, horizontal, vertical and
diagonal grid lines were overlaid and used to count the number of
saccular septa intersections. We calculated MLI as follows: length of
grid lines divided by the number of intersections with saccular septa.
Data are from three samples of each indicated genotype.
Using the same images, we drew approximately 30–50 lines per
ﬁeld perpendicular to the narrowest segment of saccular septa in
order to measure saccular wall thickness. The mean length of lines
crossing the septa was determined using Scion Image (Scion Corp.)
We generated proliferation index for mesenchymal cells by
counting the percentage of PCNA-positive mesenchymal cells in
4–5 ﬁelds of view from 3 different lungs.
Video image, statistical and densitometry analyses
Video image analysis of vacular wall remodeling was per-
formed for PECAM stained sections as previously described
(Mushaben et al., 2012). Brieﬂy, we used Metamorph imaging
software (v6.2; Universal Imaging/Molecular Devices) to measure
the medial wall thickness and external diameter of each vessel. For
each vessel, wall thickness and the external diameter were
measured twice, along two different (crossed) axes. Percent wall
thickness was calculated as [(wall 1a thickness+wall 1b thickness)/
external diameter 1]100 (Mushaben et al., 2012). We perform
this calculation for each axis. Each axis measurement was aver-
aged together to determine the ﬁnal wall thickness. Between 4 and
6 vessels were measured for each mouse. Statistical analysis was
performed as described previously (El-Hashash et al., 2005,
2011a,c). Protein quantiﬁcation was produced by densitometry
analysis with the Image J software as described (El-Hashash et al.,
2011c). Data were analyzed using ANOVA-Dunnett′s test and
values considered signiﬁcant if Po0.05.Results
Six1 and Eya1 act together to regulate lung development
We recently reported that the expression of Eya1 and Six1
overlaps at the distal mesenchyme and epithelium of the devel-
oping lung and that Eya1 / or Six1/ mouse embryos exhibit
severe lung hypoplasia, which is characterized by a reduction of
epithelial branching, but increased mesenchymal cellularity (El-
Hashash et al., 2011a, b). Therefore, to further test whether these
genes function in a molecular pathway during murine lung
development, we generated and examined the lungs of compound
homozygotes of Eya1/;Six1 / (Fig. 1). Eya1/;Six1/ homo-
zygous lungs exhibited hypoplasia that was more severe than the
degree of Eya1 / or Six1 / lungs (Fig. 1A and D–G). The
newborn pups of these mice gasped for breath, appeared cyanotic
and died at birth similar to Eya1/ or Six1 / mice. Histological
sections of E14.5 and E18.5 Eya1 /;Six1 / hypoplastic lungs
Fig. 1. Eya1 and Six1 act together to regulate lung development. External appearance (A) and histology ((D)–(K)) show that Eya1/;Six1/ homozygous lungs exhibit
hypoplasia that is more severe than the degree of Eya1/ or Six1/ lungs, with increased saccular wall thickness (insets in (H)–(J)) and a few epithelial branches, but more
dense mesenchymal cellularity. (B) Six1 co-immunoprecipitates Eya1 protein in vivo. Endogenous Six1 was immunoprecipitated from E14.5 lung cell lysates with Six1
antibody and Western blotting was performed with Eya1 or Six1-speciﬁc antibodies. (C) Western blot of E14.5 lungs shows decreased Eya1 expression in Six1/ lungs, but
no apparent change in Six1 expression in Eya1 / lungs. ((L)–(S)) Both lung bronchial epithelial wall ((L)–(O), and (L′)–(O′) that shows CC10 antibody staining; arrows) and
vascular adventitia ((P)–(S); arrows) in mutant lungs are extensively thickened at the saccular phase. ((P)–(S)) Note extensive remodeling of pulmonary vessels in mutant
mice, compared to wildtype. (T) Immunocytochemistry shows no apparent change in Six1 expression after Eya1 knockdown, but reduced Eya1 expression, which localized to
both nucleus and cytoplasm/tight junctions (Fougerousse et al., 2002; Xiong et al., 2009; El-Hashash et al., 2012), after Six1 knockdown in MLE15 cells. Scale bars: 50 μm.
K. Lu et al. / Developmental Biology 382 (2013) 110–123112conﬁrmed that the volume of the lung parenchyma was reduced
and there were a few epithelial branches and airways, but more
dense mesenchymal cellularity, compared to Eya1 / or Six1 /
lungs (Fig. 1D–K). In Eya1/ or Six1/ lungs, expansion of
epithelial tubules did occur and primitive pre-alveoli existed but
were greatly reduced compared to wildtype lungs (Fig. 1H–J, and
El-Hashash et al., 2011a, b). However, in the hypoplastic Eya1 /;
Six1/ lungs, arrested expansion of epithelial tubules, increased
ratio of interstitial mesenchyme to epithelial tubules, and the
apparent failure of normal lung maturation (interstitial condensa-
tion), which should occur in late lung development, were more
severe than Eya1/ or Six1/ lungs (Fig. 1I–K). Similarly, Eya1 /;
Six1 / homozygous lungs exhibited more severe defects than
Eya1 / or Six1 / lungs in the saccular wall thickness, mesench-
ymal cell proliferation and differentiation, as well as capillary
development at E18.5 (Figs. 2–4), as discussed later.Next, we determined whether Eya1 and Six1 could interact in
the lung in vivo by co-immunoprecipitation and Western blot
assays. As shown in Fig. 1B, Six1 co-immunoprecipitated Eya1
protein from lung cell lysates. Moreover, the expression of Eya1
was Six1-dependent because Eya1 protein expression was almost
undetectable in E14.5 Six1 / lung cell lysates. Conversely, Six1
expression did not apparently change in Eya1 / lungs (Fig. 1C).
This was further conﬁrmed by loss of function experiments in
MLE15 lung epithelial cells in vitro. Indeed, Eya1 expression was
reduced after knocking down Six1, while Six1 expression did not
apparently change in Eya1siRNA-transfected cells (Fig. 1T).
Together, these results suggest that Six1 is upstream to Eya1 and
that both genes reside within the same molecular pathway that
controls lung development. In harmony with this conclusion, both
Eya1 and Six1 proteins physically interact in vitro and in cultured
cells (Buller et al., 2001).
Fig. 2. Defective saccular wall thickness and primitive alveoli in Eya1/Six1 heterozygous lungs. ((A)–(D)) Representative sections of heterozygous lungs show increased
saccular wall thickness, compared to wildtype littermates. Representative yellow lines are drawn at 901 across saccular walls. (E) Results of morphometry assessing saccular
wall thickness of the experiments shown in (A)–(H) (n¼3; Po0.001). nSigniﬁcantly different from control (ANOVA-Dunnett test). (F) Mean linear intercept (MLI) calculation
of experiments shown in (A)–(H) shows narrowed airspace in mutant lungs (n¼3; Po0.05). nSigniﬁcantly different from control (ANOVA-Dunnett test). Data are mean7s.e.m.
Scale bars: 50 μm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. Increased mesenchymal cell proliferation in Eya1/Six1 mutant lungs at the saccular phase. ((A)–(D)) Immunostaining for PCNA shows increased cell proliferation in
the lung parenchyma in Eya1 / or Six1/ mice compared with controls. This increase is more abundant in Eya1 /;Six1/ homozygous lungs. (E) Results of
morphometric analyses for quantitation of PCNA-positive cells, which is expressed as a percentage of all counted cells, of the experiments shown in (A)–(D). nSigniﬁcantly
different from control (Po0.05; ANOVA-Dunnett test). Data are mean7s.e.m. ((F)–(N)) Double-staining for PCNA and SP-C ((F)–(I); arrows) or for PCNA and α-SMA ((K)–(N);
arrows). Arrows refer to co-localization. (J) Results of morphometric analyses for the experiments shown in (F)–(N) showing that PCNA is abundantly colocalized with
α-SMA. In contrast, PCNA positivity only infrequently colocalizes with AT2 cell marker SPC. Data expressed as a percentage of all counted cells. nSigniﬁcantly different from
control (n¼300; Po0.05; ANOVA-Dunnett test). Data are mean7s.e.m. Scale bars: 50 μm.
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and lung remodeling in Eya1 / , Six1 / or Eya1 /; Six1 /
double mutant lungs
During the saccular phase, lung development involves a num-
ber of critical morphological processes, including growth and
widening of distal airways, differentiation of alveolar epithelialtype I and type II (AT1/AT2) cells, and thinning of the air–blood
barrier. Subsequently, the saccules divide dichotomously, giving
rise to terminal air spaces, as well as the distal air spaces expand
and the capillary networks encompassing them reorganize to lie in
close apposition to the epithelium as the interstitial tissue thins.
Therefore, the saccular phase is an essential developmental stage,
which prepares the distal lung for the subsequent formation of
Fig. 4. Increased mesenchymal and ﬁbroblast cell differentiation in Eya1/Six1 mutant lungs at the saccular phase. ((A)–(D) and (F)–(M)) Immunoperoxidase staining shows
increased expression levels of collagen-1, FSP1 and N-cadherin (arrows) in all mutant lungs compared with control littermates. This increase is more abundant in Eya1/;
Six1/ homozygous (arrows) compared with Eya1/ or Six1 / lungs. (E) Western blotting for experiments shown in (A)–(D) and (F)–(M). Bars in (E) represent quantiﬁed
Western blot signals (n¼2). Scale bars: 50 μm.
K. Lu et al. / Developmental Biology 382 (2013) 110–123114alveoli during the alveolar phase and gas exchange at birth (Burri,
1985; Warburton et al., 2010).
The histology of control wildtype lungs showed thinning of the
septae in the lung parenchyma at E18.5 (Fig. 1H). In contrast,
Eya1 / , Six1/ or Eya1 /;Six1 / lungs exhibited an increase
in parenchymal cellularity and extensive thickening of the septae
in the saccules (Fig. 1I–K), as well as thickening of the bronchial
epithelial wall (Fig. 1L–O and L′–O′) and arteries (perivascular
mesenchyme; Fig. 1P–S), compared with wildtype lungs at E18.5.
In addition, both immunostaining and Western blot at E18.5
showed more AT2 cells in Eya1 / , Six1 / or Eya1 /;Six1 /
lungs compared with controls, as evident with increased SP-C and
SP-B expression levels (Supplementary Fig. S1A–I). This suggests
abnormalities in epithelial morphology and differentiation in
mutant lungs. Interestingly, the increase of AT2 cell differentiation
was greater in Eya1/;Six1 / than Eya1/ or Six1 / lungs
(Fig. S1D, E and I). In addition, overexpression of Eya1 was able to
restore the expression level of SP-C, which was upregulated after
Six1 knockdown in MLE15 cells in vitro (Fig. S1J–M). This further
suggests that both Eya1 and Six1 function together in the lung
epithelium, and Six1 is upstream to Eya1 in the lung.
Furthermore, the histology of different mutant lungs showed
evidences of vascular remodeling (Fig. 1P–S). This was further
conﬁrmed in sections stained with the platelet endothelial cell
adhesion molecule (PECAM), which is used extensively as a
murine vascular marker (Fig. 5J′–M′). Vessel wall thickness was
measured by morphometric analysis as previously described in
detail (Mushaben et al., 2012). This morphometric analysis
revealed signiﬁcant increases in wall thickness in different mutant
lungs, compared to control wildtype lungs (Fig. 5N).
The ratio of interstitial mesenchyme to epithelial tubules
strongly increased in Eya1/ or Six1 / lungs and became more
severe in Eya1 /;Six1/ homozygous lungs (Fig. 1I–K). This
hindered the speciﬁc measurements of defects in the saccular
wall thickness and primitive alveoli at saccular phase. To facilitate
these measurements, we therefore generated Eya1+/; Six1+/compound heterozygous mice, in addition to Eya1+/ and
Six1+/ mice, which all showed mild to severe hypoplastic lung
phenotypes (Fig. 2A–D and data not shown). The pooled results of
these quantitative analyses are given in Fig. 2E. There was a
signiﬁcant 1.5–1.7-fold increase of the saccular wall thickness of
Eya1+/ or Six1+/ lungs as compared with controls. More increase
(2.5 fold) in the saccular wall thickness was found in Eya1+/;
Six1+/ heterozygous lungs (Fig. 2E and A–D).
Next, we turned to a more speciﬁc measurement of the defect
of primitive alveolar septal development: mean linear intercept
(MLI), which was measured as described in “Materials and
methods” section. As shown in Fig. 2A, E18.5 wildtype lungs had
well developed primitive air sacs. Eya1+/ or Six1+/ lungs also
formed primitive air sacs, but they had a signiﬁcant decrease in
the MLI (Fig. 2F), reﬂecting smaller primitive air sacs that were
more severe in Eya1+/;Six1+/ heterozygotes (Fig. 2B–D). The
average MLI for each group is given in Fig. 2F. Together, these data
suggest increased saccular wall thickness, but decreased airspace
size of primitive sacs at the saccular phase even after removing
one copy of the Eya1 or Six1 gene. This phenotype became more
severe upon deletion of the two copies of Eya1 or Six1 gene
(compare Fig. 1I–K with Fig. 2).
Increased mesenchymal cell proliferation and differentiation as well
as abnormal capillary development in Eya1 / or Six1 / lungs
Since the saccular walls of mutant lungs appeared to be
hypercellular (Figs. 1 and 2), we next determined whether
increased cell proliferation was contributing to the parenchymal
thickening in mutant lungs. The number of PCNA-positive cells
signiﬁcantly increased in Eya1/ or Six1 / lungs compared to
wildtype littermates (1.7–1.9-fold increases; Fig. 3A–E). This
increase was bigger in magnitude (2.3-fold increases) in
Eya1/;Six1/ homozygous lungs (Fig. 3D and E). The increase
of PCNA levels was further conﬁrmed by Western blot (Fig. 4E).
These proliferative cells were abundant in mutant lungs, especially
Fig. 5. Eya1/Six1 mutant lungs exhibit increased elastin and α–SMA but abnormal capillary development. ((A)–(I)) Speciﬁc antibody staining shows increased expression of
both elastin and α-SMA (arrows) in mutant lungs compared with littermate mice. (E) Western blotting for experiments shown in (F)–(I). Blue numbers represent relative
band intensity. ((J)–(M)) Immunohistochemistry shows PECAM signal existed in smaller vessels at distal lung parenchyma (arrows) in control lungs (J). In mutant lungs,
PECAM signal is disorganized and scattered in smaller vessels throughout the lung parenchyma ((K)–(M)). ((J)–(M)) high magniﬁcation shows the wall thickness of blood
vessels in PECAM stained sections (K)–(M) (marked with an asterisk in (K) and (M), and not shown in (J) and (L)). (N) Percent wall thickness of blood vessels was increased
1.4–1.9 fold in different mutant mice (n¼3; Po0.05). nSigniﬁcantly different from control (ANOVA-Dunnett test). Data are mean7s.e.m. Scale bars: 50 μm.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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To speciﬁcally identify which cells were proliferating during the
saccular stage of lung development, we performed ﬂuorescent
double-labeling experiments for PCNA with the epithelial marker
SPC or the mesenchymal/myoﬁbroblast marker α-SMA. Interest-
ingly, less than 5% of the PCNA-positive cells were SPC-positive,
while over 78% of the PCNA-positive cells were also SMA-positive
(Fig. 3F–I, J and K–N). About 10–20% of the PCNA-positive cells did
not label with either SMA or SPC, and most of these cells appeared
to be epithelial/endothelial, or inﬂammatory cells. These data
suggest that the mesenchyme/myoﬁbroblasts, but not the epithe-
lium, were the cells undergoing proliferation in mutant lungs.
In harmony with these results, we previously reported decreased
cell proliferation, but increased differentiation of distal epithelial
cells/primitive alveoli in Eya1 / or Six1/ lungs at E18.5 (El-
Hashash et al., 2011a, b). This is probably because of loss of the
balance between self-renewal and differentiation (El-Hashash
et al., 2011c).
The increase of SMA-positive cells prompted us to analyze
changes in mesenchymal/ﬁbroblast cell differentiation in order to
further characterize the abnormally thick parenchyma of mutant
lungs. Closer inspection of E18.5 Eya1 / or Six1 / lungs revealed
that the expression levels of mesenchymal speciﬁc markers
collagen-1 and N-cadherin and the ﬁbroblast-speciﬁc protein1
(FSP-1) markedly increased in mutant lungs compared to controls
(Fig. 4A–D and F–M). This increase was more abundant in Eya1/;Six1/ homozygotes (Fig. 4D and I). These results were conﬁrmed
by Western blot (Fig. 4E). A similar increase was also shown in
mutant lungs for elastin and α-SMA (Fig. 5A–I), which is a hallmark
of myoﬁbroblasts (Lin et al., 2011). Together, these data indicate an
increase of the production and accumulation of extracellular matrix
(ECM) proteins (collagen-1 and elastin) and enhanced SMA expres-
sion, consisting with increased nonalveolar parenchymal tissue in
mutant lungs. This suggests that Six1-Eya1 signaling regulates
mesenchymal and ﬁbroblast cell differentiation.
Next, we investigated the alterations of vascular development
in Eya1 / , Six1 / or Eya1 /;Six1 / mutant lungs at E18.5 by
staining for PECAM, a marker for vasculature including capillaries.
Wildtype lungs demonstrated PECAM signal in large vessels and in
saccular and primitive alveolar structures (Fig. 5J and data not
shown). In comparison, mutant lungs showed a disorganized
PECAM signal that was scattered throughout E18.5 lungs, particu-
larly from smaller vessels within saccular walls (Fig. 5K–M). This
suggests abnormal capillary development in mutant lungs.
SHH, but not TGF-β, signaling pathway is a central mediator for the
histologic alterations described in association with the disrupted
saccular phase phenotypes in Eya1 / or Six1 / lungs
We next determined the molecular mechanisms whereby the
absence of Eya1 or Six1 activity results in disrupted saccular phase
phenotypes. We ﬁrst postulated that TGF-β signal hyperactivity
Fig. 6. Increased SHH signaling activity in Eya1/Six1 mutant lungs at the saccular phase. Immunohistochemistry shows increased expression levels of SHH ((A)–(D) and (F)–
(I)), Patched-1 ((J)–(M)) and Gli ((O)–(R)) proteins in the lung parenchyma at E14.5 and E18.5 compared with control littermates. (E) Western blots of E18.5 lungs with anti-
serine phosphorylated Smad3 antibody show no marked change in Smad3 activity in mutant lungs compared with control littermates. (N) Western blot analysis of SHH for
experiments shown in (F)–(I). Blue numbers in (E) and (N) represent relative band intensity. Scale bars: 50 μm. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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especially because TGF-β overexpression in prenatal or postnatal
murine lungs results in severe histologic alterations including
abnormal alveolar structure, cellular composition and vascular
development (Vicencio et al., 2004; Ahlfeld and Conway, 2012).
Western blotting analysis using E18.5 lung extracts showed similar
levels of phosphor-Smad3, which is a TGF-β signaling effector,
between different genotypes (Fig. 6E). This suggests that TGF-β-
Smad3 pathway is not involved in disrupted saccular phase
phenotypes of Eya1/ or Six1/ lungs.
Next, we thought of the possibility that SHH pathway is the
mediator for the histologic alterations described in association
with disrupted saccular phase phenotypes in mutant lungs. Three
lines of reasoning led us to investigate the function of SHH
signaling in disrupted saccular phase phenotypes in mutant lungs.
Firstly, Eya1, Six1 and SHH proteins have a similar expression
pattern in distal lung epithelial tips (El-Hashash et al., 2011a, b).
Second, SHH signaling stimulates mesenchymal cell proliferation
and differentiation, and upregulates the expression of α-SMA and
collagen (Bellusci et al., 1997a; Weaver et al., 2003; Shannon and
Hyatt, 2004; Bolaños et al., 2012), similar to Eya1/ or Six1 /
lung phenotype (Figs. 3 and 4). Finally, E18.5 Eya1 / or Six1 /
lung phenotype reported herein is very similar to transgenic mice
in which Shh is ectopically expressed (Bellusci et al., 1997a). In
addition, Six1 and Eya1 appeared to act together to regulate SHH
signaling activity because the expression levels of SHH, its receptor
Patched1 and its effector Gli were more abundant in Eya1 /;Six1/ than in Eya1 / or Six1/ lungs (Fig. 6A–D and F–R).
Notably, in all three mutant genotypes, the expression of SHH,
Patched1 and Gli continued to increase after E16.5, which is a time
point where SHH/Patched1/Gli expression starts to decrease pro-
gressively in wildtype lungs (Bellusci et al., 1997a, b), until birth
(Fig. 6A–D and F–R).
We next tested the effect of inhibiting SHH activity on mutant
lung phenotypes. We cultured E14.5 whole lungs from Eya1 / or
Six1 / embryos and maintained the organs culture for 4–5 days,
which corresponds roughly to E18.5 lungs growing in vivo, in the
presence or absence of the speciﬁc SHH antagonist, cyclopamine (Yao
et al., 2002). Indeed, the thickness of the saccular septae and distal
parenchyma as well as mesenchymal/ﬁbroblast differentiation had
apparently rescued in cyclopamine-treated lungs (Fig. 7). In the
presence of 5 μmol/l cyclopamine, mutant lungs exhibited less
thickness of the septae and lung parenchyma, and showed more
well developed primitive alveoli compared to untreated mutant
lungs (compare Fig. 7B–C and with Fig. 1I–J). In addition, the
expression levels of N-cadherin and FSP-1 markedly reduced in
cyclopamine treated-mutant lungs and were comparable to controls
(Fig. 7 F–O).
Furthermore, we tested the hypothesis that excessive SHH
pathway activity causes the disrupted saccular phase phenotypes
of Eya1/ lungs in vivo by conditional genetic reduction of 50% of
SHH activity in the distal epithelium of Eya1/ lungs using
Eya1/; Spc-rtTA+/-tet(o) Cre+/-ShhΔ/WT (Eya1 /-ShhΔ/WT)
compound mutant mice. We also performed conditional genetic
Fig. 7. Effect of cyclopamine-mediated inhibition of the SHH pathway on disrupted saccular phase phenotypes in mutant lungs. ((A)–(C) and (A′)–(C′)) Substantial rescue of
airspace, primitive alveoli, and saccular wall thickness, albeit relatively wider in diameter ((A)–(C)), as well as bronchial wall thickness ((A′)—(C′); arrows) in mutant lungs at
saccular phase, which are treated with to 5 μmol/l cyclopamine, compared with control lungs. ((F)–(J)) Immunohistochemistry shows increased expression of N-cadherin
(arrows) in Eya1 / or Six1/ lung parenchyma, which is restored to near-control levels after treatment with 5 μmol/l cyclopamine. ((K)–(O)) Immunohistochemistry
shows increased expression of FSP-1 (arrows) in Eya1/ or Six1/ lung parenchyma, which is restored to near-control levels after treatment with 5 μmol/l cyclopamine.
Scale bars: 50 μm.
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lungs using Six1 /; Spc-rtTA+/-tet(o) Cre+/-ShhΔ/WT (Six1 /
-ShhΔ/WT) compound mutant mice as described in “Materials and
methods” section. No changes in the lung histology, phenotype or
protein expression were evident in DOX-fed Spc-rtTA and Spc-rtTA-
tet(o) Cre mice (data not shown). Close inspection
of these mice showed that the compound mutant lungs of
Eya1 /-ShhΔ/WT or Six1/-ShhΔ/WT were well-developed, com-
pared to Eya1 / or Six1/ lungs. They showed reduced
mesenchymal cellularity, which was relatively comparable to
wildtype control lungs, compared to corresponding lungs of
Eya1 / or Six1/ littermates. This was evident by both histolo-
gical analysis (Fig. 8A–E) and proliferation index analysis (PCNA
staining; Fig. 8G–I and L–M). These data were also conﬁrmed by
counting positive cells and Western blot for PCNA (Fig. 8J and K).
In addition, in compound mutant lungs, the saccular wall thick-
ness and primitive alveolar septal development as well as the
thickness of vascular/artery adventitia were restored to a near-
control levels seen in E18.5 wildtype lungs (Fig. 8A, D, E and N).
The pooled results of these quantitative morphometric analyses of
wall thickness and the MLI were given in Fig. 8F and F′.
Furthermore, the expression levels of the extracellular matrix
protein collagen1 and FSP-1 (Figs. 8O–T and 9G–L) as well as
α-SMA (Fig. 9A–F) in compound mutant lungs were also restored
to a near-control levels seen in E18.5 wildtype lungs, compared to
Eya1 / or Six1 / littermate lungs. These results were further
conﬁrmed by Western blot (Figs. 8R and 9D, J). Taken together, our
results show that the conditional genetic reduction of SHH activity
in Eya1/ or Six1 / deﬁcient lungs can, at least partially, rescue
the disrupted saccular phase phenotypes. This suggests that SHH
pathway is a central mediator for the histologic alterations
described in association with disrupted saccular phase phenotypes
in mutant lungs.Discussion
Despite exciting progress in elucidating important genes
involved in lung development and disease, the molecular mechan-
isms governing lung saccular and alveolar development and their
disorders remain relatively unexplored. We have recently reported
that Six1 and Eya1 transcription factors control epithelial cell
proliferation and differentiation as well as branching morphogen-
esis in the lung (El-Hashash et al., 2011a, b). Herein, we have
extended these observations to the lung mesenchyme to demon-
strate that these transcription factors are also critical regulators of
mesenchymal cell proliferation and differentiation as well as
ﬁbroblast differentiation. We have also provided the ﬁrst evidence
that Six1 and Eya1 transcription factors may function in a
molecular pathway to control the saccular stage of lung morpho-
genesis. In addition, we have provided the ﬁrst evidence that
impairment of Six1-Eya1-SHH signaling pathway results in dis-
rupted saccular phase phenotypes.
Functional roles of Six1-Eya1 signaling in saccular lung development
Saccular phase of lung development precedes the formation
of deﬁnitive alveoli. The later occurs by secondary septation
of primitive saccules during the alveolar phase, which is a critical
postnatal event (Burri, 1985, 1997). Interference with normal
lung development at the saccular phase triggered by the abnormal
environment to which an infant is exposed upon preterm
birth results in severe lung diseases such as bronchopulmonary
dysplasia (BPD). BPD is characterized by abnormal alveolar
formation with thick septae (Coalson, 2003; Baraldi and
Filippone, 2007). Herein, we demonstrate that loss of Eya1 and/orSix1 gene interferes with normal saccular development, and
causes severe mesenchymal and vascular remodeling in the
prenatal lung. This results in severe disrupted saccular phase
phenotypes.
Notably, analysis of epithelial morphology and differentiation
indicated that neonatal mortality in Eya1 / or Six1/ mutant
mice is not due to severe defects in epithelial maturation or
surfactant deﬁciency. Indeed, the expression levels of the differ-
entiation markers SP-C and SP-B (this study, El-Hashash et al.,
2011a, b) are increased in mutant mice. Lung histology shows that
there is extensive mesenchymal thickening with increased cellu-
larity, defected pre-alveolarization with thick saccular walls,
abnormal capillary development, and vascular remodeling, in the
lung parenchyma of Eya1- or Six1-deﬁcient mice (this study).
An expanded mesenchyme, increased interstitial cellularity, abnor-
mal alveolar formation, hypercellular septae, and vascular remo-
deling as well as altered lung function are characteristics of the
pathology and pathophysiology of infants with BPD (Jobe, 1999;
Coalson, 2000; Dishop, 2011).
A striking feature shown in mutant lungs herein is the marked
increase of the production of ﬁbrous ECM proteins collagen and
elastin that are the most abundant ECM proteins. In addition, SMA
expression increased in mutant lungs, in concomitant with
increased nonalveolar parenchymal tissue. These data strongly
suggest an intensive prenatal activation and differentiation of both
mesenchymal and ﬁbroblast cells, which express ﬁbrous ECM
proteins and α-SMA, in mutant lungs. Indeed, deposition and
remodeling of ECM components, including collagens, elastin,
ﬁbronectin and proteoglycans, are critical for alveolar septation.
The expression levels of these proteins are up-regulated coinci-
dentally with alveolar septation in the lung postnatally (Plumb
et al., 1987; Mariani et al., 2002; Thibeault et al., 2003). Interest-
ingly in infants with lung diseases such as BPD, collagen archi-
tecture is markedly distorted, with thickened and disorganized
ﬁbers (Thibeault et al., 2003), while septal elastin produced by
myoﬁbroblasts increases in ventilated infants who died of BPD
(Thibeault et al., 2000).
To our knowledge this is the ﬁrst study to describe the function
of Six1-Eya1 signaling in mesenchymal/ﬁbroblast cell differentia-
tion and ECM production in the lung or other organs. Indeed, we
found an abundant overlap expression of Six1 and Eya1 in the
distal lung mesenchyme (El-Hashash et al., 2011a, b), which
differentiates prenatally to smooth muscle, cartilages and
endothelial cells of blood vessels (deMello et al., 1997; Partanen
et al., 1996), and postnatally to myoﬁbroblasts in the tips of the
alveolar septae (Bostrom et al. 1996; Kapanchi and Gabbiani, 1997).
Six1 and Eya1 are also co-localized with FGF10 in the sub-
mesothelial mesenchyme (El-Hashash et al., 2011a, b), which
serves as progenitors to parabronchial smooth muscle cells (De
Langhe et al., 2008). The precise molecular mechanisms for the
effect of Six1-Eya1 signaling pathway in the differentiation of
ﬁbroblasts into α-SMA expressing myoﬁbroblasts requires further
investigation, including the potential for this pathway to regulate
genes involved in ﬁbroblast activation.
SHH, but not TGF-β pathway is a central mediator for the histologic
alterations described in association with disrupted saccular phase
phenotypes in Eya1/Six1-deﬁcent lungs
Six1 and its co-activator Eya1 are critical positive regulators of both
cell proliferation and smooth muscle progenitor cell differentiation,
which decrease in Six1-or Eya1-deﬁcent mice, in different organs such
as kidney and inner ear (Li et al., 2003; Zheng et al., 2003; Schlosser
et al., 2008; Kumar, 2009; Nie et al., 2010). Therefore, the increased
mesenchymal cell proliferation and SMA expression in Six1- or Eya1-
deﬁcent lungs is likely to be due to an indirect effect of Six1-Eya1
Fig. 8. Genetic reduction of SHH activity substantially rescues the disrupted saccular phase phenotypes in mutant mice. ((A)–(E)) Histological analysis of homozygous
mutant lungs shows increased saccular wall thickness, which is substantially rescued in Eya1/-ShhΔ/WT or Six1/-ShhΔ/WT compound mutants compared with wildtype
control lungs. Representative yellow lines are drawn at 901 across saccular walls. (F) Results of morphometry assessing saccular wall thickness of the experiments shown in
(A), (D) and (E) that show no signiﬁcant change, compared to wildtype control lungs. (F′) Mean linear intercept (MLI) calculation of experiments shown in (A), (D) and
(E) show no signiﬁcant difference of the airspace between wildtype and compound mutant lungs (ANOVA-Dunnett test). Data are mean7s.e.m. ((G)–(I) and (L)–(M))
Immunostaining for PCNA shows increased cell proliferation in Eya1 / or Six1/ lungs, which is restored to near-control levels in Eya1 /-ShhΔ/WT or Six1 /-ShhΔ/WT
lungs. (J) Results of morphometric analyses for quantitation of PCNA-positive cells, which is expressed as a percentage of all counted cells, of the experiments shown in (G),
(L) and (M). Note no signiﬁcant change in the percentage of PCNA-positive cells between compound mutant and control lungs. (Po0.05; ANOVA-Dunnett test). Data are
mean7s.e.m. (K) Western blot analysis of PCNA for experiments shown in (G), (H), (L) and (M). Blue numbers in (K) and (R) represent relative band intensity. (N) Comparable
vascular/artery adventitia (arrow), which increases in mutant mice, between wildtype control and Eya1/-ShhΔ/WT or Six1 /-ShhΔ/WT lungs. ((O)–(Q) and (S)–(T))
Immunohistochemistry shows increased collagen1 expression (arrows) in Eya1/ or Six1/ lungs, which is restored to near-control levels in Eya1 /-ShhΔ/WT or Six1 /
-ShhΔ/WT lungs. (R) Western blot analysis of collagen1 for experiments shown in (O), (P), (S) and (T). Scale bars: 50 μm. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
K. Lu et al. / Developmental Biology 382 (2013) 110–123 119
Fig. 9. Substantial rescue of ﬁbroblast differentiation and capillary development after genetic reduction of SHH activity in mutant mice. ((A)–(C) and
(E)–(F)) Immunohistochemistry shows increased α-SMA expression in Eya1 / or Six1 / lung parenchyma (arrows), which is restored to near-control levels in Eya1 /
-ShhΔ/WT or Six1/-ShhΔ/WT lungs. (D) Western blot analysis of α-SMA for experiments shown in (A), (B), (E) and (F). Blue numbers in (D) and (J) represent relative band
intensity. ((G)–(I) and (K)–(L)) Immunohistochemistry shows increased expression of FSP-1 (arrows) in Eya1/ or Six1 / lung parenchyma, which is restored to near-
control levels in Eya1/-ShhΔ/WT or Six1 /-ShhΔ/WT lungs. (J) Western blot analysis of FSP-1 for experiments shown in (G), (H), (K) and (L). Scale bars: 50 μm. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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tion by upregulating the expression and/or activity of other key
regulators of these two processes. TGF-β overexpression in pre- or
postnatal murine lungs results in histologic lung defects at the saccular
phase (Vicencio et al., 2004; Ahlfeld and Conway, 2012) that are
similar, at least partially, to those described herein for Eya1- or Six1-deﬁcent lungs. Overexpression of bioactive TGF-β1 in neonatal mouse
lungs results in abnormal sacular and pre-alveolar structure, cellular
composition, and vascular development. This includes thick, hypercel-
lular septal walls and poor pre-alveolar development, accumulation of
ECM proteins, increased mesenchymal cell proliferation as well as
α-SMA (Vicencio et al., 2004; Ahlfeld and Conway, 2012). In addition,
Fig. 10. A schematic model showing how Six1/Eya1 coordinates interactions with SHH/FGF10 signaling to control both mesenchymal development and epithelial branching
in the lung. Based on our current results and published data (El-Hashash et al., 2011a, b), we suggest that Six1/Eya1 focally expressed in distal mesenchyme inhibits Patched
1 (Ptc1) receptor expression, and thus they maintain focal FGF10 expression by inhibiting local SHH activity (interactions 1 and 2; right panel). The response of distal tip
epithelial cells to FGF10 is further proposed to be facilitated because epithelial Six1Eya1 signaling also inhibits SHH expression and/or autocrine activity in these cells
(interactions 3 and 4; right panel). Six1/Eya1-controlled SHH activity level is also critical for proper mesenchymal cell proliferation and differentiation in the developing lung
(left panel).
K. Lu et al. / Developmental Biology 382 (2013) 110–123 121overexpression of TGF-β1 in adult models has been shown to result in
massive accumulation of ECM proteins, such as the collagens in lung
parenchyma (Sime et al., 1997; Gauldie et al., 1999).
However, TGF-β is unlikely to be a mediator for disrupted
saccular phase phenotypes in Eya1- or Six1-deﬁceint mice because
its activity did not apparently change in these mice (this study).
Conversely, activation of SHH signaling is more likely to be a
central mediator for the histologic alterations described in asso-
ciation with disrupted saccular phase phenotypes in Eya1- or Six1-
deﬁceint lungs. In harmony with this conclusion, SHH is co-
expressed with Eya1/Six1 in distal lung epithelial tips (El-
Hashash et al., 2011a, b), and its activity increased in Eya1- or
Six1-deﬁceint mice (this study). In addition, SHH signaling stimu-
lates mesenchymal cell proliferation and differentiation, and
upregulates the expression of α-SMA, collagen. In addition, over-
expression of Shh increases the ratio of interstitial mesenchyme to
epithelial tubules (Bellusci et al., 1997a; Weaver et al., 2003;
Shannon and Hyatt, 2004; Bolaños et al., 2012), similar to Eya1 /
or Six1/ lung phenotype. Our ﬁndings that genetically lowering
SHH activity in Eya1- or Six1-deﬁcent lungs substantially rescues
the disrupted saccular phase phenotypes in vivo provide strong
evidence that SHH may act as a central mediator for the histologic
alterations described in association with saccular phase pheno-
types in mice lacking Eya1 or Six1.
Notably, both Six1 and Eya1 have a localized expression pattern
in the mesenchyme at the very distal tips of the branching buds (El-
Hashash et al., 2011a, b), which is very similar to that of FGF10
(Bellusci et al., 1997b). Indeed, we found that both Six1 and Eya1 are
co-localized with FGF10, a mesenchymal cell marker (De Langhe
et al., 2008), in the distal lung mesenchyme (El-Hashash et al.,
2011a, b). It has been suggested that SHH signaling activity acts to
facilitate proper FGF10 localization during distal tip branching by
inhibiting FGF10 expression, mainly in the inter-bud regions after
the expression of mesenchymal FGF10 has been initiated (Chuang
and McMahon, 2003). However, SHH expression is upregulated at
new sites of branching, which is associated with higher levels of
FGF10 expression. This creates an apparent paradox as to how
FGF10 expression can be maintained in the presence of high levels
of SHH expression (Chuang and McMahon, 2003). Based on our
current results about Six1/Eya1 functions in the lung mesenchyme
and our published studies on their role in lung epithelial branching
morphogenesis (El-Hashash et al., 2011a, b), we propose a model in
which Six1/Eya1 signaling is essential to control SHH/FGF10 expres-
sion pattern and activity during lung development (Fig. 10). We
propose that Six1/Eya1 focally expressed in distal mesenchymeinhibits Ptc1 receptor expression and thus maintains focal
FGF10 expression by inhibiting local SHH activity (interactions
1 and 2; Fig. 10). The response of distal tip epithelial cells to
FGF10 is further proposed to be facilitated because epithelial Six1/
Eya1 signaling is also necessary to inhibit SHH expression and/or
autocrine activity in these cells (interactions 3 and 4; Fig. 10). The
autocrine functions of SHH have been well documented during the
development of different organs (McGlinn and Tabin, 2006; Yang
et al., 2008; Handrigan and Richman, 2010). In addition, Six1/Eya1
modulation of SHH expression levels in the epithelium as well as
activity levels in the mesenchyme affects on lung mesenchymal cell
proliferation and differentiation. Ectopic SHH expression/activity
levels result in increased mesenchymal cell proliferation and
differentiation after genetic deletions of Six1 and/or Eya1 (Fig. 10;
left panel). This model strongly suggests that Six1/Eya1 signaling is
critical for proper lung development and the regulation of SHH
signaling activity in the lung. This is supported by several lines of
evidence, including the remarkable recue of both mesenchymal cell
proliferation and differentiation (current study) as well as lung
epithelial branching morphogenesis (El-Hashash et al., 2011a, b)
after genetic reduction of SHH signaling in Six1 / or Eya1/
mutant mice in vivo, or inhibition of SHH activity in culture that
also restores FGF10 expression levels (El-Hashash et al., 2011a, b).
Another type of evidence is the similarity of the time of effect on
lung branching between Six1/Eya1 and SHH signaling. Indeed,
abrogation of Six1 or Eya1 (El-Hashash et al., 2011a, b) negatively
impinges on lung branching morphogenesis, subsequent to the
ﬁrst round(s) of domain branching, which is similar to Shh /
lungs (Pepicelli et al., 1998). Moreover, the expression levels of
Shh, Six1 and Eya1 are downregulated in the differentiation phase
of lung development (El-Hashash et al., 2011a, b; Bellusci et al.,
1997a).
To our knowledge, this is the ﬁrst study that describes the
importance of Six1-Eya1-SHH signaling pathway in the saccular
lung development. Therefore, it is likely that SHH signaling activity
must be tightly regulated by Six1-Eya1 signaling in order to enable
normal lung morphogenesis. Our future studies will focus on the
determination of Six1-Eya1-SHH functional and molecular
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